- Will CAR-NK Cancer Therapy Surpass High-Cost CAR-T Immunotherapy?
- What is the role of Platelet Dynamics in Cancer Progression?
- Biomarkers can detect rapid aging of organs and disease risks
- Avoiding “Off-Target” Effects: Researchers Enhance the Safety of Future mRNA Therapies
- Japan: Sales Halted for ‘Cannabis Gummies’ as Health Issues Mount
- Evaluation of the carcinogenicity of organic fluorine compounds raised by WHO subsidiary
Sweden and Denmark suspended Moderna COVID-19 vaccines for young people due to serious side effects
- FDA Investigates T-Cell Malignancy Risk in CAR-T Cell Therapy
- WHO Requests More Information from China on Pediatric Clustered Pneumonia
- First Chinese PD-1 Cancer Drug 30 Times More Expensive in U.S. than in China
- Cardiovascular Diseases Linked to COVID-19 Infections
- What is the difference between dopamine and dobutamine?
- How long can the patient live after heart stent surgery?
Sweden and Denmark suspended Moderna vaccines for young people.
Just now, Sweden suspended Moderna vaccination for people born in 1991 and later. The reason is that vaccination leads to an increased risk of side effects, such as myocarditis or pericarditis.
Denmark has also found side effects of the vaccine and has suspended the Moderna vaccine for people under 18 years of age. Moderna’s COVID-19 vaccine is hit again!
Reuters reported that the Swedish health authorities suspended the use of Moderna’s COVID-19 vaccine for people 30 years of age and under on October 6, saying the move was for preventive purposes.
The Swedish Public Health Agency said in a statement that the reason for the suspension was “signals indicating an increased risk of side effects, such as inflammation of the myocardium or pericardium.”
Anders Tegnell, Sweden’s chief epidemiologist, said that they “closely monitor the situation and act quickly to ensure that the vaccine against COVID-19 is always as safe as possible while providing effective protection”.
In July of this year, the European Medicines Agency recommended that Moderna’s COVID-19 vaccine be authorized for use in children aged 12 to 17.
In January of this year, Moderna’s COVID-19 vaccine was approved for use in people aged 18 and over in the 27 EU member states.
It has also been licensed in countries including the United Kingdom, Canada and the United States, but so far, its use has not been extended to children.
To date, Pfizer vaccine is the only vaccine approved for use in children under the age of 18 in Europe and North America.
Hundreds of millions of Moderna’s COVID-19 vaccines have been used in adults. U.S. and European regulators reminded that Moderna Pfizer’s COVID-19 vaccine seems to be related to a rare reaction in adolescents and young adults-chest pain and heart inflammation.
Swedish health authorities say that cardiac symptoms “usually go away on their own,” but must be evaluated by a doctor. These conditions are most common among young men. In 2019, about 300 people under the age of 30 were treated in hospital for myocarditis.
Data shows that the incidence of COVID-19 vaccination has also increased, mainly among adolescents and young adults, but mainly among boys and men.
According to the Swedish Public Health Agency, the latest preliminary analysis in Northern Europe shows that this connection is particularly evident when it comes to the Moderna vaccine, especially after the second dose of the vaccine.
The increase in risk is seen within four weeks after vaccination, mainly in the first two weeks.
The Swedish Public Health Agency said it recommends that people in these age groups use Pfizer’s vaccine. Its decision to suspend Moderna’s COVID-19 vaccine is valid until December 1.
The Danish Health Service said on October 6 that in Denmark, for precautions, Denmark will not provide Moderna vaccines to people under the age of 18.
Data collected from four Nordic countries shows that although the number of cases of heart inflammation is still very low, the risk of heart disease may increase when vaccinated with Moderna vaccine.
Morderna submits third dose application to Canada
At the same time, Moderna gave it a go to apply for the third stitch to Canada!
Health Canada said today that it has received an application for booster vaccines from Moderna.
Health Canada said it is conducting a “thorough, independent and evidence-based review” of the application.
The booster injection data submitted by Moderna is half the dose used for the first and second vaccine injections so far.
Last month, the company said that there are signs that the longer people get vaccinated, their immunity is weakening.
The National Advisory Committee on Immunization (NACI) has recommended high-risk Canadians, such as residents of long-term care homes, as well as people with moderate to severely weakened immunity, to receive booster doses of the COVID-19 vaccine.
Earlier this year, Prime Minister Trudeau announced that the country will receive 35 million booster doses of vaccine from Pfizer.
Health Canada stated that NACI will continue to monitor the ever-changing evidence regarding enhanced doses for key populations and the public, and will update the guidelines as needed.
Canadian public health and vaccine experts are cautious about recommending booster injections to most Canadians, because so far, vaccines have shown strong protection against serious diseases, even though their protection against infections is declining.
Due to the unfair distribution of vaccines between rich and poor countries, there is also controversy over increasing injections.
Millions of people around the world cannot even get a single dose of the vaccine. The World Health Organization has asked countries to restrict booster injections so that other countries can also get the vaccine.
(source:internet, reference only)
Important Note: The information provided is for informational purposes only and should not be considered as medical advice.